About Den Mark Pharmaceuticals
Den Mark Pharmaceuticals is a company. Den Mark Pharmaceuticals has raised $719.96 thousand across 1 funding round. The company has 137 employees as of March 24, 2025. Den Mark Pharmaceuticals offers products and services including Capsules and Tablets.
- Employees 137 as on 24 Mar, 2025
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Den Mark Pharmaceuticals Pvt. Ltd
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$2.77 M (USD)317.36as on Mar 31, 2024
-
Net Profit
-$1.86 M (USD)-3473.37as on Mar 31, 2024
-
EBITDA
-$1.59 M (USD)-3249.37as on Mar 31, 2024
-
Total Equity Funding
$719.96 K (USD)
in 1 rounds
-
Latest Funding Round
$719.96 K (USD), Seed
Nov 11, 2023
-
Investors
Not available
-
Employee Count
137
as on Mar 24, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Den Mark Pharmaceuticals
Den Mark Pharmaceuticals offers a comprehensive portfolio of products and services, including Capsules and Tablets.
Capsules are produced as part of the range for third-party contract manufacturing services.
Tablets are manufactured to meet the needs of pharmaceutical marketing companies.
People of Den Mark Pharmaceuticals
Unlock access to complete
Funding Insights of Den Mark Pharmaceuticals
Den Mark Pharmaceuticals has successfully raised a total of $719.96K through 1 strategic funding round. The most recent funding activity was a Seed round of $719.96 thousand completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Den Mark Pharmaceuticals
Investment portfolio details for Den Mark Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Den Mark Pharmaceuticals
Detailed financials for Den Mark Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Den Mark Pharmaceuticals Comparisons
Peer comparison for Den Mark Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Den Mark Pharmaceuticals
Detailed competitors of Den Mark Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Den Mark Pharmaceuticals
Complete news archive for Den Mark Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Den Mark Pharmaceuticals
Den Mark Pharmaceuticals is a funded company, having raised a total of $719.96K across 1 funding round to date.
As of Mar 24, 2025, the latest employee count at Den Mark Pharmaceuticals is 137.
Annual revenue of Den Mark Pharmaceuticals is $2.77M as on Mar 31, 2024.
Den Mark Pharmaceuticals is recognized for providing third-party contract manufacturing services tailored for pharmaceutical companies in India and abroad. The facility in Roorkee, India, spans over 66,000 square feet and is equipped with advanced infrastructure, including segregated blocks for different medicine groups and certifications like WHO-GMP and ISO 9001:2015. Services encompass dossier preparation, registration support, technology transfer, and global exports, with a commitment to quality assurance and innovation in healthcare. Operations are guided by experienced leadership, ensuring compliance and efficiency in production.
Den Mark Pharmaceuticals offers Capsules and Tablets.